Methods for the detection of autologous blood-doping
OwnerChrister MALM, Nelson KHOO +4inventors
InventorsChrister MALM, Nelson KHOO, Irene GRANLUND, Pernilla LINDÉN, Michael HALL, Raik WAGNER
Life of this patent
Estimating the term…
Loading patent…
OwnerChrister MALM, Nelson KHOO +4inventors
InventorsChrister MALM, Nelson KHOO, Irene GRANLUND, Pernilla LINDÉN, Michael HALL, Raik WAGNER
Estimating the term…
The present invention relates to the identification of peptides, and the corresponding proteins, that can be used in methods for the detection of autologous blood doping. More specifically, the invention relates to methods comprising tryptic digestion of samples of isolated red blood cell (RBC), specifically isolated RBC cytosol, followed by peptide mapping using liquid chromatography tandem-mass spectroscopy (LC-MS/MS). The methods according to the invention which enable detection of increased levels of certain peptides in samples from subjects that have been subjected to autologous blood doping, compared to samples from non-doped control subjects.
A method for detection of autologous blood-doping with cryopreserved blood in a subject, said method comprising the step:
A method as claimed in any previous claim wherein the reference blood sample is from a non-doped subject.
The method according to any previous claim wherein said one or more specific peptides is or are one or more peptides derived from one or more of the proteins listed in Table 3.
The method according to any previous claim wherein said one or more specific peptides is or are one or more peptides selected from the list of peptides comprising SEQ ID Nos:
The method according to any previous claim wherein said one or more specific peptides is or are 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, or 78 peptides selected from the list of peptides comprising SEQ ID Nos:
The method according to any previous claim wherein said one or more specific peptides is or are one or more peptides derived from one or more of the proteins selected from:
The method according to any previous claim wherein said one or more specific peptides is or are one or more peptides consisting of the amino acid sequence of one of the peptides SEQ ID Nos:
The method according to any previous claims wherein the step of generating the proteolytic peptide map comprises protease digestion that is performed using one or more of the proteases selected from trypsin, chymotrypsin, Lys-C, Gly-C, Asp-N, Arg-C, papain.
The method according to any previous claim wherein the peptide mapping is performed by the combination of liquid chromatography (LC) with mass spectrometry (MS), and preferably wherein the MS is tandem mass spectrometry (MS/MS).
Use of a peptide selected from the list of peptides comprising the peptides SEQ ID Nos:
A peptide consisting of the amino acid sequence of one the peptides SEQ ID Nos:1, 7, 8, 14, and 34.
A method for the identification of biomarkers for the detection of autologous blood-doping with cryopreserved blood, said method comprising the steps;
Dependencies are inferred from the claim text.